×
Newsmax TV & Webwww.newsmax.comFREE - In Google Play
VIEW
×
Newsmax TV & Webwww.newsmax.comFREE - On the App Store
VIEW
Tags: Germany | BioNTech

COVID-vaccine Maker BioNTech Reports $1.37B Profit in Q1

Monday, 10 May 2021 09:01 AM

BERLIN (AP) — German pharmaceutical company BioNTech reported a net profit of 1.13 billion euros ($1.37 billion) in the first quarter of this year on the back of strong revenues from its coronavirus vaccine.

The company's estimated revenues surged to over 2 billion euros for the period from January to March, compared with just 28 million euros in the same period last year.

BioNTech developed the first widely used vaccine against COVID-19 together with U.S. partner Pfizer, which holds the market and distribution rights in much of the world.

The Mainz-based company said its revenues included over 1.75 billion in gross profits from vaccine sales in Pfizer's territories, and almost 200 million from sales to customers in its region.

BioNTech shares rose by more than 8% to $198.55 in pre-market trading on Nasdaq Monday.

The results are a significant turnaround for the company, which made a net loss of 53 million euros in the first quarter of 2020.

Early last year as the pandemic began, BioNTech pivoted from researching treatments for cancer to developing a vaccine against COVID-19. Like its rival Moderna, the company's vaccine uses mRNA technology to prime the body's immune system to attack the virus.

© Copyright 2021 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.


GlobalTalk
German pharmaceutical company BioNTech reported a net profit of 1.13 billion euros ($1.37 billion) in the first quarter of this year on the back of strong revenues from its coronavirus vaccine.The company's estimated revenues surged to over 2 billion euros for the period...
Germany,BioNTech
197
2021-01-10
Monday, 10 May 2021 09:01 AM
Newsmax Media, Inc.
Join the Newsmax Community
Register To Comment Login To Comment
Please review Community Guidelines before posting a comment.
 
 
TOP

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
© Newsmax Media, Inc.
All Rights Reserved
NEWSMAX.COM
© Newsmax Media, Inc.
All Rights Reserved